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outcomes of aortobifemoral bypass in India
Indrani Sen, MS, Edwin Stephen, MS, and Sunil Agarwal, MS, Vellore, India
Objective: Aortoiliac arterial occlusive (AIOD) disease is common in India. The clinical presentation and etiology are
different than in the West. Intervention is frequently required for advanced lower extremity ischemia, but the results have
not been systemically evaluated. We studied the clinical proﬁle and midterm results of patients undergoing aortobifemoral
bypass for AIOD at a tertiary care center in south India.
Methods: Clinical data of patients undergoing aortobifemoral bypass for AIOD over a 6-year period from January 1, 2005
to December 31, 2010 were retrospectively analyzed. Clinical presentation and factors affecting outcome were evaluated.
Graft patency and mortality were included as study end points.
Results: Ninety-nine patients (mean age, 52 years) with AIOD who underwent aortobifemoral bypass were included.
Etiology included atherosclerosis in 79 patients, thromboangiitis obliterans in 15, Takayasu’s arteritis in two, and
hematological conditions in 3. Smoking (82%), hypertension (40%), and diabetes (30%) were the most common risk
factors; ischemic heart disease (4%), obesity (2%), and dyslipidemia (3%) were rare. Eighty-one percent of patients pre-
sented with critical limb ischemia. Mean duration of symptoms was 22 months (range, 4 months to 9 years). Concomitant
infrainguinal arterial occlusive disease was identiﬁed in 81%, but intervened upon in only 2%. In-hospital mortality was
3%. Causes of death included myocardial infarction in two and colon ischemia in one. Major morbidity included nonfatal
myocardial infarction (3%), pneumonia/atelectasis (5%), and renal dysfunction (2%). Groin wound complications
occurred in 20%, seroma/lymph leak in 13%, infection in 7%, and anastomotic hemorrhage in 2%. Multidrug-resistant and
polymicrobial infections were common. Early graft thrombosis (30 days) occurred in 15 patients; 8 of 11 reintervened
grafts were salvaged. Four more grafts thrombosed during a mean follow-up of 2 years (range, 0-5 years) and two became
infected. Overall study major limb loss rate was 10% (primary, 2%; secondary, 8%). Delayed presentation and smoking
were more common in patients developing complications. There was no signiﬁcant difference in overall complication rates
between patients with thromboangiitis obliterans and atherosclerosis (P [ .66).
Conclusions: Despite earlier age at presentation, atherosclerosis remains the predominant etiology of aortoiliac arterial
occlusive disease in Indian patients. Results of open revascularization are comparable to those in the Western literature.
Thromboangiitis obliterans is the underlying pathology in a minority of patients with no signiﬁcant difference in
operative outcome. Patients frequently present late with critical limb ischemia, but this does not affect outcome. (J Vasc
Surg 2013;57:20S-5S.)Aortoiliac arterial occlusive disease (AIOD) is com-
monly seen in tertiary referral centers on the Indian sub-
continent. Atherosclerosis, thromboangiitis obliterans
(TAO), and vasculitis (eg, Takayasu’s arteritis) are the
common etiologies. Patients often present late with
progressive critical limb ischemia (CLI). CLI is known to
be associated with a high risk of major limb loss, myocardial
infarction, stroke, and death.1-4 The estimated rate of all-
cause mortality in patients with CLI has been reported to
be as high as 20% within 6 months of diagnosis and
surpasses 50% at 5 years postdiagnosis.5,6 Data on the clin-
ical presentation of Indian patients with AIOD and the
outcomes of surgical revascularization are lacking. In addi-
tion, it is not known if the younger age at presentation,the Department of Vascular Surgery, Christian Medical College.
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://dx.doi.org/10.1016/j.jvs.2012.06.113differing etiology, and greater incidence of diabetes melli-
tus in the Indian population affect mortality and limb
salvage following revascularization. The aim of this study
was to study the clinical proﬁle and midterm results of
patients undergoing aortobifemoral bypass for AIOD at
Christian Medical College, Vellore, India, a tertiary care
center in south India (Fig 1).
METHODS
Clinical data of consecutive patients undergoing aorto-
bifemoral bypass for AIOD at the Christian Medical
College from January 1, 2005 to December 31, 2010
were retrospectively analyzed. Demographic data, comor-
bid medical conditions, history and physical ﬁndings, diag-
nostic and laboratory test results, operative records,
postoperative complications, graft patency, and mortality
were recorded. Complete follow-up was deﬁned as data
obtained within 12 months of the end point of the study.
Patients were contacted by phone for an update if they
were unable to return for a follow-up visit. The study was
approved by the institutional review board.
Patients were diagnosed with atherosclerosis or vascu-
litis on the basis of clinical examination, imaging, and
biochemical tests. TAO was diagnosed on the basis of
Fig 1. Map of India indicating the location of Christian Medical College, Vellore.
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not resolving after 2 weeks of adequate analgesia, ischemic
tissue loss (ulceration or gangrene), ankle brachial pressure
index <.3 (nondiabetics), or toe pressure <30 (diabetics).
A few patients known to have vasculitis or hematological
disorders (leukemia in remission, polycythemia) also pre-
sented with symptoms of AIOD and were included in the
study. All patients in this cohort had a TransAtlantic Inter-
Society Consensus C or D pattern of disease. The
treatment of the underlying condition was managed by
Rheumatology and Hematology, respectively. Patients
undergoing ileofemoral bypass for segmental iliac disease
were excluded. All patients were on best medical manage-
ment (antiplatelets, lipid-lowering agents, antihypertensive
agents, insulin/oral hypoglycemic agents, as indicated) at
the time of operation. Aspirin was used in all patients.
Patients with additional risk factors (severe, coronary artery
disease, hypercoagulable states) also received clopidogrel
or oral anticoagulation (warfarin/Acitrom). All patients
were taught lifestyle modiﬁcations and most received
low-dose statins.All operations were open and were performed electively
(except one) in patients with CLI, acute on chronic
ischemia, or disabling limb claudication. Proximal and
distal graft anastomoses were end-to-side in conﬁguration
and were performed to the healthiest areas of the target
arteries. The distal anastomoses were extended onto the
profunda femoris artery in patients with occlusion of the
superﬁcial femoral artery. Early thrombosis was deﬁned as
thrombosis occurring within 30 days, intermediate as occur-
ring up to 2 years, and late as occurring after 2 years. Graft
patency was deﬁned by clinical examination and imaging
(duplex ultrasonography/computed tomography angiog-
raphy/magnetic resonance angiography/digital subtraction
angiography). Primary amputation was any amputation per-
formed simultaneously at the index operation. Secondary
amputation was deﬁned as any amputation performed
subsequently, during the same hospitalization or during
follow-up. Minor amputation was deﬁned as loss of a
toe or forefoot, and major amputation, as a below-knee,
above-knee, or hindquarter disarticulation. Reinterven-
tion was any procedure in the postoperative period to
Table I. Patient demographics and operative details
(n ¼ 99)
Demographics No. of patients
Age 53 (28-73)a
No. of women 9
Clinical features
CLI 81
Disabling claudication 16
Acute on chronic ischemia 2
Risk factor
Smoking 81
Hypertension 40
Diabetes 29
Dyslipidemia 3
Obesity 2
Systemic comorbidities
Coronary artery disease 5
Chronic obstructive pulmonary disease 1
Renal insufﬁciency 2
Asthma, chronic liver disease, hepatitis,
chronic myeloid leukemia
4
Etiology
Atherosclerosis 79
Thromboangiitis obliterans 15
Takayasu’s arteritis 02
Hematological conditions 03
Human immunodeﬁciency virus 01
Anesthesia
General 57
Spinal/epidural 31
Combined 11
Type of graft
Dacron 60
Polytetraﬂuoroethylene 16
Silver impregnated 8
Graft size
12  6 mm 34
14  7 mm 44
16  8 mm 2
Primary amputation
Major 2
Minor 11
Medications
Antiplatelets (aspirin, clopidogrel) 99
Oral anticoagulation 9
CLI, Critical limb ischemia.
aAverage (range).
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sent in cases of surgical site infections. Surveillance inter-
vals after the index admission were very irregular; this is
due to the large distances patients on the subcontinent
need to travel to seek medical care. However, in patients
with recurrent or new symptoms, repeat imaging was
performed.
Statistical analysis. Statistics were analyzed using
SPSS software, and Kaplan-Meier curves were generated.
The c2 test and Fisher exact test for signiﬁcance were
performed, with P < .05 considered signiﬁcant. Outcome
analyses were done with the Kaplan-Meier method to
determine freedom from thrombosis. We subdivided the
patients into three main groups for the purpose of statistical
analysis: group I included patients with atherosclerosis,
group II included those with TAO, and group III included
patients with other etiologies.
RESULTS
Patient demographics, diagnosis, and operative
details. Over the 6-year study period 99 patients under-
went aortobifemoral bypass at our institution. This cohort
represents all patients who underwent surgery in this
period. There were 88 men (91%) and nine women (9%)
with a mean age of 53 years regardless of gender (range:
women, 42-70; men, 28-73). The median age of the
patient cohort was also 53 years; 40 (41%) were less than
50 years old and 90% less than 65 years old at presentation.
More than half the patients had to travel an average of
2200 km from their place of residence for medical care for
the operative intervention.
Demographic and procedural details are outlined in
Table I. Atherosclerosis was the etiology in 79% of patients,
TAO (Fig 1) in 15%, and vasculitis in 2%. There were two
other patients with chronic myeloid leukemia, one with
human immunodeﬁciency virus and one with polycy-
themia, in the group. The majority of patients (81%) pre-
sented with CLI (81%), with a mean duration of
symptoms at presentation of 22.26 months (range,
0-108). Two patients presented with acute on chronic
limb ischemia. Smoking was the most common risk factor.
The incidences of symptomatic cardiovascular (5%) and
pulmonary (1%) comorbidities were low, but this may be
the result of poor documentation. Routine preoperative
evaluation for cardiopulmonary disease included an electro-
cardiogram and chest radiograph; cardiac stress and pulmo-
nary function tests were not routinely performed. All
aortobifemoral bypasses were primary procedures and
were performed electively, except in one instance. Associ-
ated infrainguinal arterial occlusive disease of varying
severity was present in 81% of patients, but the aortic lesion
was determined to be the critical ﬂow-limiting lesion in all
patients. Four patients were diagnosed to have concomi-
tant infrainguinal ﬂow-limiting lesions: two underwent
a simultaneous femoral-to-popliteal artery bypass graft;
the other two patients opted to have the distal graft at
a second admission (Table II). Surgery was performed
under regional (spinal, epidural: patient sedated but awakewith no endotracheal intubation or mechanical ventilation)
anesthesia in 31%, general anesthesia in 57%, and combined
anesthesia in 31%. Preoperatively, the case was discussed
with the anesthesiologist with respect to suitability for
regional anesthesia. Anesthesiologists noted that use of
regional anesthesia reduced the need for postoperative
ventilation and intensive care unit care. Epidural anelgesia
also helped in postoperative pain relief. Graft materials
included Dacron in 60, ePTFE in 16, and silver-
impregnated Dacron in eight. In all patients, aortic size
was <2 cm. The AIOD was infrarenal in the majority
of patients, and end-to-side aortic anastomosis was the
rule. The common femoral artery was the most common
outﬂow target. All patients received prophylactic ﬁrst-line
antibiotics at induction. As per institutional antibiotic
Table II. Overall early and late postoperative
complications after aortobifemoral bypass
Postaortobifemoral complications No. of patients
Mortality 4
Within 30 days 3
Late 1
Complications
Myocardial infarction 3
Pulmonary complications 5
Renal insufﬁciency 2
Seroma, lymph leak 13
Femoral anastomotic hemorrhage 2
Ground wound infections 7
Antibiotic sensitivity pattern
Organism isolated First line Second line Pan resistant
Pseudomonas 6
Escherichia coli 5
Klebsiella 1 4
Staphylococcus aureus 1 3
Nonfermenting
gram-negative bacteria
3 1
Other 4
Graft infection 2
Thrombosis 20
Early 15
Intermediate 2
Late 2
Reinterventiona
Graft thrombectomy 8
Graft ligation 2
Thrombolysis 1
Explant 2
Secondary amputation 8
Major 7
Minor 1
aSome patients had more than one.
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are considered ﬁrst line for use in patients whodonot present
with tissue loss. In patients with tissue loss, second-line anti-
biotics are recommended: second- to fourth-generation
cephalosporins, ampicillin-clavulanic acid, and piperacillin-
tazobactam. Vancomycin and carbapenems are reserved
for reoperations. Administration of antibiotics is guided by
the clinical scenario and based on microbial culture sensi-
tivity patterns. Discussion of antibiotic policy in view of the
prevalent infection pattern is limited here as the study was
retrospective.
Early outcomes. Three patients died postoperatively,
yielding a 30-day (in-hospital) mortality of 3% (3/99).
Two patients died from a myocardial infarction. The third
patient developed hypotension and acidosis on post-
operative day 2, and was found to have colonic ischemia
involving the entire colon on re-exploration. He underwent
total colectomy, but succumbed to multisystem organ
failure and disseminated intravascular coagulation. Major
morbidity occurred in 10% of patients: nonfatal myocardialinfarction (3%); pulmonary complications (pneumonia/
atelectasis, 5%); renal insufﬁciency 2%. No patient required
hemodialysis. Groin wound complications occurred in 20%
of patients and included seroma/ lymph leak in 13% and
wound infection in 7%. Two of the latter patients developed
graft infection and anastomotic hemorrhage requiring rein-
tervention. The microbiological proﬁle of the patients with
groin/graft infection was studied. A single microorganism
was identiﬁed in one patient; ﬁve patients had multiple
multidrug-resistant organisms cultured from their wounds.
Early graft thrombosis (within 30 days) occurred in
15 patients. Four patients (three with severe outﬂow
obstruction and one with hypercoagulability) refused reop-
eration and were managed conservatively with no resultant
limb loss. Eleven patients underwent reintervention (graft
thrombectomy 6 revision of anastomoses); this failed in
three patients, all of whom underwent secondary major
amputation. Severe outﬂow obstruction, hypercoagulable
state, and graft infection were the causes of failure in these
three patients. Patency was restored in eight patients; early
failure was attributed to a technical problem alone in three
patients and to outﬂow obstruction in ﬁve.
Mean duration of hospital stay was 10 days. After
discharge from the hospital, most patients remain in the
city and return home only after their initial period of conva-
lescence. All patients were discharged on aspirin. Nine
patients with graft thrombosis or a diagnosed hypercoagu-
lable state were discharged on oral anticoagulation with
Coumadin. The numbers of patients who underwent
inﬂow and outﬂow procedures in a single operative setting
were too small to analyze outcome. One of these patients
had early graft thrombosis and underwent graft thrombec-
tomy, after which patency was restored.
Late outcomes. Mean follow-up was 2 years (range, 4
months to 5 years). Ten patients were lost to follow-up
immediately after the operation. Follow-up data were
available for 89 patients (89%). One patient died from
hypertensive renal failure in the third postoperative year.
Four additional grafts thrombosed during follow-up: two
intermediate and two late. All grafts that were intervened
upon for early graft thrombosis remained patent during
follow-up. The graft failures were felt to be secondary to
progressive infrainguinal/aortic disease. Two of these
patients underwent unsuccessful surgical reintervention
with eventual major amputation for worsening gangrene.
The third patient underwent thrombolysis complicated by
pituitary apoplexy and, hence, was managed conservatively
but with no limb loss. Patients shared a ward with other
general and colorectal surgery patients. Wound infection
was most commonly polymicrobial (Table II).
Two of seven patients with early wound infection
developed graft infection, which required explantation
within the ﬁrst year. One culture revealed Staphylococcus
aureus; no organism was isolated in the other patient.
The overall graft patency rate at last follow-up was
84%. In addition to the two primary and three early
secondary amputations from graft thrombosis, four patients
suffered major limb loss during follow-up; two with graft
Table III. Univariate analysis of risk factors for
postoperative graft-related complications
Characteristic
No. of patients
P value
Disease etiology
Atherosclerosis (79) Other (20)
Seroma 10 0 .007
Wound infection 5 2 .16
Graft infection 1 1 .352
Secondary amputation 5 4 .99
Thrombosis 13 6 .66 (Kap)
Smoking
Present (81) Absent (10)
Seroma 12 1 .99
Wound infection 7 0 .99
Graft infection 2 0 .99
Secondary amputation 3 3 .99
Thrombosis 15 4 .99
CLI
Present (81) Absent (19)
Seroma 12 1 .25
Wound infection 7 0 .17
Graft infection 2 0 .65
Secondary amputation 8 0 .17
Thrombosis 18 1 .08
CLI, Critical limb ischemia; Kap, signiﬁcance derived from survival estimate
analysis.
Fig 2. Kaplan-Meier curve for risk of thrombosis according to
etiology.
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salvage rate of 90%.
Analysis of risk factors. Presentation with CLI,
smoking, atherosclerotic risk factors, and disease etiology
were analyzed to study the risk for groin wound infection,
graft infection, seroma, and thrombosis using the c2 test
and Fisher exact test. Patients with etiology other than
atherosclerosis were grouped together for these analyses,
as the numbers of patients with etiologies other than
TAO in this group were small. The data are summarized
in Table III. Though the P value for risk of developing
a seroma according to disease etiology was statistically
signiﬁcant, the numbers in this group were small, and
hence it is not considered a positive result. Kaplan-Meier
analysis was used to analyze the effect of etiology
(groups: atherosclerosis, TAO, other) on outcome
(thrombosis) (Fig 2). There was no signiﬁcant association
with etiology (P ¼ .66). This is probably due to the small
numbers of patients in the study group.DISCUSSION
This is one of the largest and most comprehensive
reports of aortofemoral bypass from India. Several aspects
of this clinical series are unique. More than 80% of patients
presented with CLI. Patients were relatively younger andpresented late with advanced disease. Very few patients
had undergone preoperative cardiac imaging or interven-
tion. A large number had their operation with only regional
anesthesia. Aortic size was small, and most proximal graft
conﬁgurations were end-to-side. The relatively high rate
of early graft thrombosis was secondary to multilevel distal
occlusive disease and underlying hypercoagulable states.
Open aortobifemoral bypass is a ﬁrst-line option for
patients with TransAtlantic Inter-Society Consensus
(TASC) C and D lesions. Endovascular treatment at our
center is reserved for patients with TASC A or B lesions.
The majority of our patients do not have medical insurance.
Endovascular treatment is a more expensive option, and
affordability limits its use.
Atherosclerosis is thought to be a disease of old age.
However it is also the most common cause of peripheral
vascular disease in the young.7 The aortoiliac segment is
a common site of involvement in these patients. In patients
less than 50, entities like hypoplastic aorta syndrome,
premature atherosclerosis have also been reported.7 Athero-
sclerosis in younger patients is thought to have a more
aggressive course compared to older patients.8 Late graft
patency rates in these patients have been reported to be
signiﬁcantly lower.9-11 In our patient group, more than
half were less than 50 years old. Many patients presented
late with advanced disease and tissue loss. Though there
was no signiﬁcant difference in patient or graft-related
outcomes in patients younger than 50 years compared
with the older patients or in those with TAO as compared
with atherosclerotic AIOD, the total numbers of patients
may not be large enough in this study to draw deﬁnitive
conclusions. In addition, the length of follow-up remains
fairly short, and longer follow-up may yield different results.
Younger patients with AIOD are thought to have increased
rates of cardiovascular disease12; this too was not seen in our
patients, at least in terms of symptomatic cardiac disease.
AIOD is also thought to be related to obesity and dyslipide-
mia, but this too was not a common association in our
patients.13 Small aortic diameter is known to predispose
to graft thrombosis and has been postulated as a potential
JOURNAL OF VASCULAR SURGERY
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patients. The aortic size in our patients was small, lower
than what is commonly seen in the West; however, this
did not affect early and midterm graft patency (84%), which
was comparable to (even slightly better than) that reported
in younger patients in the literature.7-9,14
The aorta is also known to be involved in TAO, and
we see a large number of such patients. They are often not
good candidates for revascularization because of poor distal
outﬂow targets. In two patients with intermediate throm-
bosis, continuation of smoking and underlying hypercoagu-
able state were identiﬁed as probable causes. In the two
patients with late thrombosis, no deﬁnite cause was demon-
strable. Although overall graft thrombosis was higher (30%)
in patients with a nonatherosclerotic etiology of the AIOD
compared with patients with atherosclerosis (16%), this did
not reach statistical signiﬁcance, likely because of the small
numbers of patients. In addition, no other risk factors signif-
icantly predicted graft thrombosis, including delayed presen-
tation, underlying risk factors, graft type, or groin wound
infection (P >.01). The rates of groin wound infection in
our patient cohortwere not signiﬁcantly different from those
reported in the literature. As expected, groin wound infec-
tion leading to anastomotic hemorrhage or graft thrombosis
was the most common cause of secondary limb loss.
Multidrug-resistant polymicrobial infections are the most
common pattern of wound infection.
Two percent of patients in this study had graft infec-
tions, in keeping with the incidence of 1% to 6% in the avail-
able literature.15 The management of infected vascular
prosthetic grafts is variable and controversial and includes
extra-anatomic and in situ repair with antibiotic-soaked
prosthetic, cryopreserved, as well as autologous femoral
vein conduits. Given our small experience, no conclusions
can be drawn in this regard. Varied microbiological patterns
and emergence of multidrug-resistant strains have com-
pounded this problem. In this study, a large number of
patients presented with tissue loss; however, this was not
found to be signiﬁcantly associated with graft infection.
Overall our experience indicates that open aortoiliac
revascularization in relatively younger patients presenting
late with advanced lower extremity ischemia has a good
outcome and is worthwhile. There are several limitations
to our study that deserve mention. These include the retro-
spective nature of the study, the relatively small number of
patients with nonatherosclerotic aortoiliac disease, and the
incomplete documentation for a few patients. Many
patients were lost to follow-up after a year. None of these
patients, however, had postoperative complications and
likely chose not to return because of the long distance.
CONCLUSIONS
Despite the earlier age at presentation atherosclerosis
remains the predominant etiology of aortoiliac arterial
occlusive disease in Indian patients. Results of open revascu-
larization are comparable to those in the Western literature.
Thromboangiitis obliterans is the underlying pathology in
a minority of patients with no signiﬁcant difference inoperative outcome. Patients frequently present late with
critical limb ischemia, but this does not seem to signiﬁcantly
affect outcome.
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